{"schema_version":"1","generated_at":"2026-11-15T06:26:10.828Z","data_as_of":null,"url":"https://www.findmykol.com/kol/chenyang-wang","json_url":"https://www.findmykol.com/kol/chenyang-wang/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"chenyang-wang","name":"Chenyang Wang","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1205255205","orcid":"0000-0001-6798-0857","openalex":"A5100424692"},"summary":"Chenyang Wang is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 90 publications with 1,799 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":90,"cited_by_count":1799,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06287515","title":"Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06287515","trial_url":"https://www.findmykol.com/trial/NCT06287515"},{"nct":"NCT05496972","title":"Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05496972","trial_url":"https://www.findmykol.com/trial/NCT05496972"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":82425,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205255205"},{"payer":"Genentech","program_year":2025,"amount_usd":32740.07,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205255205"},{"payer":"Elekta","program_year":2025,"amount_usd":25445.18,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205255205"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1205255205","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"TPI1 enhances gemcitabine resistance in bladder cancer by promoting autophagy through activating Beclin-1","year":2025,"journal":"Cell Death and Disease","source_url":"https://doi.org/10.1038/s41419-025-08368-4","status":"verified"},{"title":"Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses","year":2025,"journal":"Journal of Neuro-Oncology","source_url":"https://doi.org/10.1007/s11060-025-05269-6","status":"verified"},{"title":"Repeat it without me: Crowdsourcing the T1 mapping common ground via the ISMRM reproducibility challenge","year":2024,"journal":"Magnetic Resonance in Medicine","source_url":"https://doi.org/10.1002/mrm.30111","status":"verified"},{"title":"Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors","year":2024,"journal":"Advances in Radiation Oncology","source_url":"https://doi.org/10.1016/j.adro.2024.101697","status":"verified"},{"title":"Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches","year":2024,"journal":"Neuro-Oncology Practice","source_url":"https://doi.org/10.1093/nop/npae004","status":"verified"}],"source":"works"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Anil Sood","slug":"anil-sood","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/anil-sood","json_url":"https://www.findmykol.com/kol/anil-sood/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}